Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Faivre

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Nature Reviews. Drug Discovery|August 11, 2007
Molecular basis for sunitinib efficacy and future clinical developmentSandrine Faivre, George Demetri, William Sargent, et al.
Molecular Cancer Therapeutics|July 11, 2007
Lessons learned in the development of targeted therapy for malignant gliomasAntonio M P Omuro, Sandrine Faivre, Eric Raymond
Therapeutic Advances in Medical Oncology|January 10, 2012
Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potentialCatherine Delbaldo, Sandrine Faivre, Chantal Dreyer, et al.
Targeted Oncology|May 24, 2020
Impact of the COVID-19 Outbreak on the Management of Patients with CancerEric Raymond, Catherine Thieblemont, Severine Alran, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2007
Molecular targeted therapy of head and neck cancer: review and clinical development challengesChristophe Le Tourneau, Sandrine Faivre, Lillian L Siu
Journal of Hepatology|April 14, 2018
New trials and results in systemic treatment of HCCMaría Reig, Leonardo Gomes da Fonseca, Sandrine Faivre
Targeted Oncology|November 14, 2009
Sunitinib paves the way for targeted therapies in neuroendocrine tumorsEric Raymond, Sandrine Faivre, Pascal Hammel, et al.
Bulletin Du Cancer|December 7, 2007
[Phase I cancer trials methodology]Christophe Le Tourneau, Sandrine Faivre, Eric Raymond, et al.
Drug Safety|August 13, 2009
Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancerNathalie Theou-Anton, Sandrine Faivre, Chantal Dreyer, et al.
Trials|November 27, 2016
Adjuvant therapies in advanced hepatocellular carcinoma: moving forward from the STORMMohamed Bouattour, Olivier Soubrane, Armand de Gramont, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Nature Reviews. Drug Discovery|August 11, 2007
Molecular basis for sunitinib efficacy and future clinical developmentSandrine Faivre, George Demetri, William Sargent, et al.
Molecular Cancer Therapeutics|July 11, 2007
Lessons learned in the development of targeted therapy for malignant gliomasAntonio M P Omuro, Sandrine Faivre, Eric Raymond
Therapeutic Advances in Medical Oncology|January 10, 2012
Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potentialCatherine Delbaldo, Sandrine Faivre, Chantal Dreyer, et al.
Targeted Oncology|May 24, 2020
Impact of the COVID-19 Outbreak on the Management of Patients with CancerEric Raymond, Catherine Thieblemont, Severine Alran, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2007
Molecular targeted therapy of head and neck cancer: review and clinical development challengesChristophe Le Tourneau, Sandrine Faivre, Lillian L Siu
Journal of Hepatology|April 14, 2018
New trials and results in systemic treatment of HCCMaría Reig, Leonardo Gomes da Fonseca, Sandrine Faivre
Targeted Oncology|November 14, 2009
Sunitinib paves the way for targeted therapies in neuroendocrine tumorsEric Raymond, Sandrine Faivre, Pascal Hammel, et al.
Bulletin Du Cancer|December 7, 2007
[Phase I cancer trials methodology]Christophe Le Tourneau, Sandrine Faivre, Eric Raymond, et al.
Drug Safety|August 13, 2009
Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancerNathalie Theou-Anton, Sandrine Faivre, Chantal Dreyer, et al.
Trials|November 27, 2016
Adjuvant therapies in advanced hepatocellular carcinoma: moving forward from the STORMMohamed Bouattour, Olivier Soubrane, Armand de Gramont, et al.
Pageof 14